Li X - Search Results

1

Safety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Expression Inhibitor GST-HG131 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation Trial.

Li X, Liu Y, Yao H, Wang M, Gao L, Lou J, Mao J, Wu W, Zhou Y, Tang Y, Yan W, Hu Y, Ding C, Chen S, Niu J, Ding Y. Li X, et al. Antimicrob Agents Chemother. 2022 May 17;66(5):e0009422. doi: 10.1128/aac.00094-22. Epub 2022 Apr 11. Antimicrob Agents Chemother. 2022. PMID: 35404074 Free PMC article. Clinical Trial.

2

Clinical evaluation of efficacy, tolerability and pharmacokinetics of yimitasvir phosphate in patients infected with hepatitis C virus.

Zhang H, Zhu X, Li Q, Lou J, Sun J, Shen Z, Chen H, Li X, Wu M, Li C, Liu J, Liu C, Hu Y, Wang J, Chen G, Ding Y, Niu J. Zhang H, et al. Among authors: li c, li x, li q. J Pharm Pharmacol. 2018 Jul;70(7):855-864. doi: 10.1111/jphp.12916. Epub 2018 Apr 6. J Pharm Pharmacol. 2018. PMID: 29630721 Clinical Trial.

3

Pharmacokinetic Profile of a Generic Formulation of Sofosbuvir and Its Metabolite GS-331007 in Healthy Chinese Subjects.

Shen Z, Zhu X, Zhang H, Chen H, Niu J, Chen G, Li X, Ding Y. Shen Z, et al. Among authors: li x. Clin Pharmacol Drug Dev. 2019 Nov;8(8):1073-1080. doi: 10.1002/cpdd.674. Epub 2019 Mar 22. Clin Pharmacol Drug Dev. 2019. PMID: 30900816 Clinical Trial.

4

Pharmacokinetics, safety, and tolerability of TQC3564, a novel CRTh2 receptor antagonist: report of the first-in-human single- and multiple-dose escalation trials in healthy Chinese subjects.

Li X, Li Q, Ji T, Zhang H, Liu J, Wu M, Chen H, Lou J, Liu C, Xu Z, Ding Y. Li X, et al. Among authors: li q. Expert Opin Investig Drugs. 2022 Jul;31(7):729-736. doi: 10.1080/13543784.2022.2078192. Epub 2022 May 18. Expert Opin Investig Drugs. 2022. PMID: 35574691 Clinical Trial.

5

Single- and multiple-dose pharmacokinetics and tolerability of limaprost in healthy Chinese subjects.

Chen H, Zhang Q, Li X, Zhang H, Sun Y, Yin L, Liu C, Cao Y, Gu J, Ding Y. Chen H, et al. Among authors: li x. Clin Drug Investig. 2015 Mar;35(3):151-7. doi: 10.1007/s40261-014-0265-3. Clin Drug Investig. 2015. PMID: 25586152 Clinical Trial.

6

Pharmacokinetics, Pharmacodynamics, and Tolerability of Single and Multiple Doses of Trandolapril, an Effective Angiotensin-Converting Enzyme Inhibitor, in Healthy Chinese Subjects.

Li X, Liu C, Wu M, Zhang H, Sun Y, Cheng L, Chen H, Liu C, Yang L, Zhang Q, Cao Y, Gu J, Ding Y. Li X, et al. Eur J Drug Metab Pharmacokinet. 2016 Aug;41(4):373-84. doi: 10.1007/s13318-015-0277-2. Eur J Drug Metab Pharmacokinet. 2016. PMID: 25864194 Clinical Trial.

7

Tolerability, pharmacokinetics and antiviral activity of rHSA/IFNα2a for the treatment of chronic hepatitis B infection.

Ding Y, Lou J, Chen H, Li X, Wu M, Li C, Liu J, Liu C, Li Q, Zhang H, Niu J. Ding Y, et al. Among authors: li c, li x, li q. Br J Clin Pharmacol. 2017 May;83(5):1056-1071. doi: 10.1111/bcp.13184. Epub 2016 Dec 20. Br J Clin Pharmacol. 2017. PMID: 27862178 Free PMC article. Clinical Trial.

8

Safety, pharmacokinetics and pharmacogenetics of a single ascending dose of pradefovir, a novel liver-targeting, anti-hepatitis B virus drug, in healthy Chinese subjects.

Ding Y, Zhang H, Li X, Li C, Chen G, Chen H, Wu M, Niu J. Ding Y, et al. Among authors: li c, li x. Hepatol Int. 2017 Jul;11(4):390-400. doi: 10.1007/s12072-017-9797-y. Epub 2017 May 30. Hepatol Int. 2017. PMID: 28560658 Clinical Trial.

9

Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects.

Zhang H, Li Q, Zhu X, Li C, Li X, Liu C, Hu Y, Chen G, Wei H, Wang J, Shen Z, Ding Y. Zhang H, et al. Among authors: li c, li x, li q. Cancer Chemother Pharmacol. 2018 Oct;82(4):615-623. doi: 10.1007/s00280-018-3645-1. Epub 2018 Jul 24. Cancer Chemother Pharmacol. 2018. PMID: 30043208 Clinical Trial.

10

Pharmacokinetics, Safety, and Tolerability of the Direct-acting Hepatitis C Antiviral Sofosbuvir in HealthyChineseSubjects.

Li X, Chen H, Niu J, Chen G, Shen G, Massetto B, Brainard DM, Zhu X, Zhang H, Ding Y. Li X, et al. Clin Ther. 2018 Sep;40(9):1556-1566. doi: 10.1016/j.clinthera.2018.07.018. Epub 2018 Sep 2. Clin Ther. 2018. PMID: 30185395 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169,495 results

Search Page